跳至主要内容
临床试验/NL-OMON48359
NL-OMON48359已完成不适用

Effects of Acetate on insulin Sensitivity, CNS regulation of food intake and appetite in Humans - AISCHA study

Academisch Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Inclusion criteria healthy lean subject group:
  • - Healthy Caucasian male or female
  • - Age 40-65
  • - Women must be post-menopausal
  • - BMI range of 19-25 kg/m²
  • - Subjects should be able and willing to give informed consent.
  • Inclusion criteria obese metabolic syndrome subject group:
  • - Caucasian male or female with metabolic syndrome
  • - Age 40-65
  • - Women must be post-menopausal
  • - BMI range of 25-40 kg/m²
  • - At least 3 out of 5 NCEP metabolic syndrome criteria: fasting plasma glucose
  • * 5.6 mmol/L and/or HOMA-IR * 2.5, triglycerides * 1.6 mmol/L,
  • waist-circumference > 102 cm, HDL cholesterol * 1.04 mmol/L, blood pressure *
  • - Subjects should be able and willing to give informed consent.

排除标准

  • Exclusion criteria for all participants:
  • - Systemic medication use, except for paracetamol
  • - Oral or intravenous antibiotics in the past 3 months before inclusion
  • - Substance abuse
  • - Excessive weight loss (> 10% in past 3 monts)
  • - Overt diabetes mellitus type 2
  • - Malignancy (except for basal cell carcinoma)
  • - History of major heart disease
  • - History of major renal disease
  • - Pregnancy or breast feeding
  • - Implantable devices
  • - Contra-indication for MRI, such as claustrophobia or pacemaker
  • - Psychiatric illnesses: mood disorders, eating disorders, anxiety disorders,
  • schizophrenia and other psychotic disorders, dissociative disorders, somatoform
  • disorders, delirium, dementia and other cognitive disorders
  • - Simultaneous participation in other studies
  • - Inability to understand the study protocol, give informed consent or
  • participate adequately in study protocol

研究者

相似试验